STERIS plc revised financial guidance for the fiscal year 2024. For fiscal 2024, the Company now expects as reported revenue to increase 10-11%, an increase from previous expectations of 9-10%. Expectations for constant currency organic revenue growth are also increased to 7-8% from prior expectations of 6-7%.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
228.6 USD | +1.17% | +10.14% | +4.12% |
02:18pm | Wolfe Research Adjusts Price Target on STERIS to $240 From $235 | MT |
01:22pm | Piper Sandler Adjusts Price Target on STERIS to $225 From $220 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.12% | 22.33B | |
-4.59% | 182B | |
+0.25% | 110B | |
-3.79% | 67.92B | |
+2.80% | 50.96B | |
+9.61% | 44.7B | |
+2.70% | 40.66B | |
+20.88% | 27.6B | |
+3.92% | 26.63B | |
-0.25% | 24.98B |
- Stock Market
- Equities
- STE Stock
- News STERIS plc
- STERIS plc Revises Financial Guidance for the Fiscal Year 2024